Walleye Capital’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,700
Closed -$11.4K 4748
2025
Q3
$11.4K Sell
2,700
-7,300
-73% -$32.1K ﹤0.01% 4270
2025
Q2
$49.8K Buy
+10,000
New +$43.4K ﹤0.01% 4038
2025
Q1
Sell
-14,400
Closed -$67K 4537
2024
Q4
$67K Sell
14,400
-6,100
-30% -$33.5K ﹤0.01% 4276
2024
Q3
$142K Buy
+20,500
New +$161K ﹤0.01% 4216

Other funds holding GDRX

Walleye Capital's GDRX Position: Q4 2025 in Review

Walleye Capital sold out of GoodRx Holdings (GDRX) in Q4 2025, closing a stake of 27,519 shares — an estimated $116K sold.

Walleye Capital first reported a position in GDRX in Q2 2021 and held it in 10 quarters. The position peaked at $2.58M in Q2 2022. 183 funds tracked by Wall St. Rank hold GDRX as of Q4 2025.

  • Walleye Capital reported no remaining GoodRx Holdings position as of Q4 2025 after selling out during the quarter.
  • Walleye Capital sold 27,519 GoodRx Holdings shares in Q4 2025, an estimated $116K.
  • Walleye Capital first reported a position in GoodRx Holdings in Q2 2021 and held it in 10 quarters.
  • Walleye Capital's GoodRx Holdings position peaked at $2.58M in Q2 2022.
  • 183 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2025.

Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.